| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 2932346
[patent_doc_number] => 05189029
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-02-23
[patent_title] => 'Indacene compounds and methods for using the same'
[patent_app_type] => 1
[patent_app_number] => 7/513059
[patent_app_country] => US
[patent_app_date] => 1990-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5387
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/189/05189029.pdf
[firstpage_image] =>[orig_patent_app_number] => 513059
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/513059 | Indacene compounds and methods for using the same | Apr 22, 1990 | Issued |
| 07/513307 | USE OF CHIRAL 2-(PHOSPHONOMETHOXY)PROPYL GUANINES AS ANTIVIRAL AGENTS | Apr 19, 1990 | Abandoned |
| 07/502334 | ANTINEOPLASTIC COMPOUNDS AND METHODS OF USING SAME | Mar 29, 1990 | Abandoned |
Array
(
[id] => 2823749
[patent_doc_number] => 05173509
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-12-22
[patent_title] => 'Suramin and active analogues thereof in the treatment of hypercalcemia'
[patent_app_type] => 1
[patent_app_number] => 7/500913
[patent_app_country] => US
[patent_app_date] => 1990-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 1
[patent_no_of_words] => 5376
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/173/05173509.pdf
[firstpage_image] =>[orig_patent_app_number] => 500913
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/500913 | Suramin and active analogues thereof in the treatment of hypercalcemia | Mar 28, 1990 | Issued |
Array
(
[id] => 2825550
[patent_doc_number] => 05116823
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-05-26
[patent_title] => 'Drug combinations containing AZT'
[patent_app_type] => 1
[patent_app_number] => 7/486062
[patent_app_country] => US
[patent_app_date] => 1990-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 2377
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/116/05116823.pdf
[firstpage_image] =>[orig_patent_app_number] => 486062
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/486062 | Drug combinations containing AZT | Feb 26, 1990 | Issued |
Array
(
[id] => 2625080
[patent_doc_number] => 04956377
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-09-11
[patent_title] => 'Use of butyl-4-diphenyl-1,2-pyrazolidine-dione-3,5 as an antiviral agent in humans and animals'
[patent_app_type] => 1
[patent_app_number] => 7/482587
[patent_app_country] => US
[patent_app_date] => 1990-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3485
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/956/04956377.pdf
[firstpage_image] =>[orig_patent_app_number] => 482587
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/482587 | Use of butyl-4-diphenyl-1,2-pyrazolidine-dione-3,5 as an antiviral agent in humans and animals | Feb 20, 1990 | Issued |
Array
(
[id] => 2840786
[patent_doc_number] => 05137870
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-08-11
[patent_title] => 'Didemnins and nordidemnins'
[patent_app_type] => 1
[patent_app_number] => 7/482372
[patent_app_country] => US
[patent_app_date] => 1990-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7020
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/137/05137870.pdf
[firstpage_image] =>[orig_patent_app_number] => 482372
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/482372 | Didemnins and nordidemnins | Feb 19, 1990 | Issued |
Array
(
[id] => 2715186
[patent_doc_number] => 05008255
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-04-16
[patent_title] => 'Method for enhancing solubility of trimethoprim with sodium sulfacetamide, and synergistic pharmaceutical compositions derived therefrom'
[patent_app_type] => 1
[patent_app_number] => 7/479827
[patent_app_country] => US
[patent_app_date] => 1990-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1726
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/008/05008255.pdf
[firstpage_image] =>[orig_patent_app_number] => 479827
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/479827 | Method for enhancing solubility of trimethoprim with sodium sulfacetamide, and synergistic pharmaceutical compositions derived therefrom | Feb 13, 1990 | Issued |
| 07/479320 | TUMOR CELL SENSITIZATION METHOD | Feb 12, 1990 | Abandoned |
Array
(
[id] => 3665127
[patent_doc_number] => 05668149
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-16
[patent_title] => 'Inhibition of human immunodeficiency virus-1 infectivity in human cells'
[patent_app_type] => 1
[patent_app_number] => 7/470692
[patent_app_country] => US
[patent_app_date] => 1990-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6759
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/668/05668149.pdf
[firstpage_image] =>[orig_patent_app_number] => 470692
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/470692 | Inhibition of human immunodeficiency virus-1 infectivity in human cells | Jan 25, 1990 | Issued |
| 07/469711 | METHOD AND PHARMACEUTICAL PREPARATION FOR CONTROLLING EMESIS CAUSED BY CISPLATIN AND OTHER EMETOGENIC AGENTS IN CANCER CHEMOTHERAPY | Jan 23, 1990 | Abandoned |
Array
(
[id] => 2587936
[patent_doc_number] => 04963588
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-10-16
[patent_title] => 'Use of ubenimex for treating myelodysplastic syndrome'
[patent_app_type] => 1
[patent_app_number] => 7/462822
[patent_app_country] => US
[patent_app_date] => 1990-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1413
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/963/04963588.pdf
[firstpage_image] =>[orig_patent_app_number] => 462822
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/462822 | Use of ubenimex for treating myelodysplastic syndrome | Jan 9, 1990 | Issued |
| 07/461671 | ANTI-SOLID TUMOR AGENTS | Jan 7, 1990 | Abandoned |
Array
(
[id] => 2861752
[patent_doc_number] => 05082865
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-01-21
[patent_title] => 'Avarol and its production and use as an antitumor agent (I)'
[patent_app_type] => 1
[patent_app_number] => 7/458948
[patent_app_country] => US
[patent_app_date] => 1989-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7548
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/082/05082865.pdf
[firstpage_image] =>[orig_patent_app_number] => 458948
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/458948 | Avarol and its production and use as an antitumor agent (I) | Dec 28, 1989 | Issued |
Array
(
[id] => 2706868
[patent_doc_number] => 05001162
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-03-19
[patent_title] => 'Use of avarone for the control of adult T-cell leukemia/lymphoma'
[patent_app_type] => 1
[patent_app_number] => 7/458893
[patent_app_country] => US
[patent_app_date] => 1989-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3768
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/001/05001162.pdf
[firstpage_image] =>[orig_patent_app_number] => 458893
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/458893 | Use of avarone for the control of adult T-cell leukemia/lymphoma | Dec 28, 1989 | Issued |
Array
(
[id] => 2671302
[patent_doc_number] => 05026732
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-06-25
[patent_title] => 'Use of avarone for the control of AIDS and ARC'
[patent_app_type] => 1
[patent_app_number] => 7/458892
[patent_app_country] => US
[patent_app_date] => 1989-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3936
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/026/05026732.pdf
[firstpage_image] =>[orig_patent_app_number] => 458892
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/458892 | Use of avarone for the control of AIDS and ARC | Dec 28, 1989 | Issued |
Array
(
[id] => 2772530
[patent_doc_number] => 05075295
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-12-24
[patent_title] => 'Novel oxytetracycline compositions'
[patent_app_type] => 1
[patent_app_number] => 7/449652
[patent_app_country] => US
[patent_app_date] => 1989-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2015
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/075/05075295.pdf
[firstpage_image] =>[orig_patent_app_number] => 449652
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/449652 | Novel oxytetracycline compositions | Dec 11, 1989 | Issued |
| 07/446154 | TREATMENT OF DISEASES CAUSED BY HERPES VIRUSES | Dec 4, 1989 | Abandoned |
Array
(
[id] => 2768069
[patent_doc_number] => 05036060
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1991-07-30
[patent_title] => 'Cyclophosphamide'
[patent_app_type] => 1
[patent_app_number] => 7/442486
[patent_app_country] => US
[patent_app_date] => 1989-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5218
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/036/05036060.pdf
[firstpage_image] =>[orig_patent_app_number] => 442486
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/442486 | Cyclophosphamide | Nov 23, 1989 | Issued |
| 07/437415 | PEPTIFLUORIN | Nov 14, 1989 | Abandoned |